|
|
 |
SENSEX
|
 |
-213.65
|
-0.85%
|
24870.10
|
|
|
NIFTY
|
 |
-693.86
|
-0.85%
|
81306.85
|
|
|
Nasdaq
|
 |
396.23
|
1.88%
|
21496.54
|
|
|
Nikkei 225
|
 |
23.12
|
0.05%
|
42633.29
|
|
|
FTSE 100
|
 |
12.20
|
0.13%
|
9321.40
|
|
|
 |
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
Cohance Lifesciences Ltd.
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Private |
BSE Code |
543064
|
ISIN Demat |
INE03QK01018
|
Book Value (Rs) |
62.24
|
|
NSE Code |
COHANCE
|
Dividend Yield % |
0.00
|
Market Cap (Rs) |
338457.15
|
|
TTM PE(x) |
130.38
|
TTM EPS(Rs) |
6.79
|
Face Value(Rs.) |
1
|
|
|
|
|
|
|
Incorporation Year
|
06-11 2018
|
Registered Office
|
215 Atrium, C Wing, 8th Floor, 819-821,Andheri, Kurla Road, Chakala,Andheri (East), Chakala Midc, Mumbai, Maharashtra-400093 .
|
ISINNO
|
INE03QK01018
|
Phone
|
022-61539999
|
E-mail
|
info@suvenpharm.com |
URL
|
www.suvenpharm.com |
Industry
|
Pharmaceuticals & Drugs
|
Chairman
|
Vivek Sharma
|
Managing Director
|
V Prasada Raju
|
Company Secretary
|
Kundan Kumar Jha
|
Listing
|
BSE,NSE
|
|
|
|
|
|
|
|
|
|
|
|